Vireo Growth (VREOF) Raw Materials (2020 - 2026)
Vireo Growth (VREOF) posted Raw Materials of $11.3 million for Q1 2026, up 20.21% sequentially from $9.4 million in Q4 2025, and up 307.82% YoY from $2.8 million in Q1 2025.
Vireo Growth (VREOF) Raw Materials (2020 - 2026) Analysis & Trends
Vireo Growth has reported Raw Materials for 7 years, with the latest figure at $11.3 million in Q1 2026.
- Quarterly Raw Materials rose 307.82% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (up 307.82% YoY) and the FY2025 annual result came in at $9.4 million, up 401.62% from the prior year.
- Raw Materials grew to $11.3 million in Q1 2026 per VREOF's latest filing, from $9.4 million in the prior quarter.
- Over five years, Raw Materials peaked at $11.3 million in Q1 2026 and troughed at $581193.0 in Q2 2023.
- A 5-year average of $2.6 million and a median of $921450.0 in 2024 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2023 and 2025: Raw Materials sank 30.17% in 2023, then jumped 506.12% in 2025.
- Over 5 years, Raw Materials stood at $791568.0 in 2022, then grew by 19.91% to $949191.0 in 2023, then soared by 97.42% to $1.9 million in 2024, then jumped by 401.62% to $9.4 million in 2025, then advanced by 20.21% to $11.3 million in 2026.
- According to Business Quant data, Raw Materials over the past three periods registered $11.3 million, $9.4 million, and $5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.30 Mn |
| Dec 31, 2025 | 9.40 Mn |
| Sep 30, 2025 | 5.59 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | 921,450.00 |
| Jun 30, 2024 | 998,022.00 |
| Mar 31, 2024 | 884,060.00 |
| Dec 31, 2023 | 949,191.00 |
| Sep 30, 2023 | 805,031.00 |
| Jun 30, 2023 | 581,193.00 |
| Mar 31, 2023 | 685,809.00 |
| Dec 31, 2022 | 791,568.00 |
| Sep 30, 2022 | 662,474.00 |
| Jun 30, 2022 | 832,326.00 |
| Mar 31, 2022 | 791,376.00 |
| Dec 31, 2021 | 674,381.00 |
| Dec 31, 2020 | 346,493.00 |